Bupivacain is one of 253 small molecule programs targeting Post Operative Pain. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
137 competitors in Atrial Fibrillation
Bupivacain
Calquence
Rituxan
Coumadin
Brukinsa
Imbruvica
Versed
Ondexxya
Romazicon
Statin
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Serratus Anterior Plane Block
NCT06856538
Genicular Nerve Block
NCT06639503
Dexmedetomidine
NCT06668220
Mastectomy
NCT06574022
Liposomal Bupivacaine
NCT05972018
Sternotomy
NCT04985500
Clinical
Sources
Details